Table 3.
Correlations between the baseline trabecular bone score (TBS) and change in TBS with selected parameters.
| Parameter | Baseline TBS | Change in TBS |
|---|---|---|
| Age | r=0.06, p= 0.84 | r=-0.18, p=0.52 |
| Baseline BMI | r=-0.72, p=0.003 | r=-0.10, p=0.71 |
| Baseline TRAb | r=0.18, p= 0.52 | r=-0.32, p=0.25 |
| Baseline TSH | r=-0.01, p= 0.97 | r=0.01, p=0.99 |
| Baseline 25(OH)D | r=0.35, p=0.20 | r=-0.03, p=0.93 |
| Baseline lumbar spine BMD | r=0.42, p=0.12 | r=0.12, p=0.67 |
| Change in lumbar spine BMD | r=0.23, p=0.41 | r=0.26, p=0.35 |
| Baseline femoral neck BMD | r=-0.27, p=0.33 | r=0.04, p=0.90 |
| Change in femoral neck BMD | r=-0.26, p=0.34 | r=0.02, p=0.95 |
| Duration of therapy with antithyroid drugs a | r=-0.15, p=0.65 | r=0.31, p=0.31 |
a
Analysis performed in 11 patients treated with antithyroid drugs throughout the study.
BMD, bone mineral density; BMI, body mass index; IVMP, intravenous methylprednisolone; TBS, trabecular bone score; TRAb, TSH receptor antibodies; TSH, thyroid-stimulating hormone.